Feature | August 03, 2020| Dave Fornell, Editor

Most Popular Cardiology Technology Content in July 2020

This is the most popular cardiac technology news content from the past month according to reader pageview analytics

Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies. 

Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies.

August 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of July 2020. This is based on the website’s 264,954 pageviews for the month. 

1. The Cardiovascular Impact of COVID-19

2. Autopsies Reveal Surprising Cardiac Changes in COVID-19 Patients

3. Novel FFR Methods Can Reduce Procedure Time and Cost 

4. New Technologies Take Cardiac CT to the Next Level 

5. New Heart Failure Devices and Drugs to Treat Heart Failure

6. Foldax Gets $20 Million to Finance Innovative Heart Valve Technology

7. The Strategic Role of Ambulatory Surgery Centers Cardiology Care

8. VIDEO: Overview of LAA Occlusion Using the Watchman FLX — Devi G. Nair, M.D

9. Edwards Lifesciences and Abbott Settle Transcatheter Mitral Valve Device Patent Litigation

10. Birmingham Cardiologist Develops New Cath Lab Radiation Protection Shielding 

11. Dapagliflozin Meets All Endpoints to Treat Chronic Kidney Disease

12. Boston Scientific's LUX-Dx Insertable Cardiac Monitor System FDA Cleared

13. Top 5 Predictions for the Global Healthcare Industry Post COVID-19

14. American Heart Association Denounces Threats to Public Health Leaders Responding to the COVID-19 Pandemic

15. Researchers 3-D Print a Beating Heart From Human Cells

16. Top 9 Cardiovascular CT Studies in Past Year

17. European Society of Cardiology Announces Late-Breaking Study Presentations at its 2020 Virtual Congress

18. VIDEO: Overview of the Interventional Labs at Tufts Medical Center — Interview with Richard Botto, CVT

19. New Study Looks at Post-COVID-19 Emerging Disease in Children

20. CeloNova Completes Enrollment of First Randomized 14-Day DAPT Trial For a Stent

21. FDA Clears Edwards Konect Resilia Aortic Valved Conduit For Complex Aortic Valve Surgeries

22. Novel Hydrogel May Help Repair Cardiac Tissue

23. FDA Clears Next-generation Watchman FLX Left Atrial Appendage Occluder

24. VIDEO: New Research in Cardiogenic Shock at Tufts Medical Center — Interview with Navin Kapur, M.D.

25. Eating Chocolate Once a Week May Reduced Risk of Heart Disease
 

 

Related Popular Cardiology Content:

Most Popular Cardiology Technology Content in June 2020

Most Popular Cardiology Technology Content in May 2020

Most Popular Cardiology Technology Content in March 2020

Most Popular Cardiology Technology Content in February 2020

Most Popular Cardiology Technology Content in January 2020

Top 25 Cardiology Videos on DAIC in 2019

The Most Popular Cardiology Topics in 2019

Related Content

Among high-risk, chronic, coronary patients who undergo angioplasty, there were no additional benefits from ticagrelor compared to the current standard of care clopidogrel. #AHA #AHA20 #AHA2020
News | Cath Lab | November 16, 2020
November 16, 2020 — The use of the more potent antiplatelet medication ticagrelor (Brilinta) was not superior to clop
A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar
Videos | Cath Lab | October 16, 2020
This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heav
Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major